Cerezyme

Cerezyme

imiglucerase

Manufacturer:

Genzyme

Distributor:

DKSH
Concise Prescribing Info
Contents
Imiglucerase
Indications/Uses
Long-term enzyme replacement therapy for patients w/ confirmed diagnosis of type 1 or 3 Gaucher disease & who exhibit ≥1 clinically significant non-neurological manifestations of anemia, thrombocytopenia, bone disease, hepatomegaly or splenomegaly.
Dosage/Direction for Use
Individualized dosage. Initially, 2.5 u/kg 3 times wkly up to 60 u/kg once every 2 wk.
Contraindications
Special Precautions
Hypersensitivity reactions in patients w/ Ab to imiglucerase. Periodically monitor for IgG Ab formation in patients suspected of decreased response. Patients on controlled Na diet. Pregnancy & lactation.
Adverse Reactions
Dyspnoea, coughing, hypersensitivity reactions, urticaria/angioedema, pruritus, rash.
MIMS Class
Other Agents Affecting Metabolism
ATC Classification
A16AB02 - imiglucerase ; Belongs to the class of enzymes. Used in the treatment of alimentary tract and metabolism problems.
Presentation/Packing
Form
Cerezyme powd for infusion 400 u
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in